# An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors

> clinical trial · VERIFIED · 2026-07-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hangzhou Sumgen Biotech Co., Ltd. · Condition: Advanced Solid Tumors

- Company: Hangzhou Sumgen Biotech Co., Ltd.
- Sector: Advanced Solid Tumors
- Primary source: https://clinicaltrials.gov/study/NCT06076291

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.